Display options
Cite
Shah SJ. Risk Marker Fatigue-Is There an Actionable Outcome?. JAMA Cardiol. 2021;6(1):78doi: 10.1001/jamacardio.2020.5616.
Shah, S. J. (2021). Risk Marker Fatigue-Is There an Actionable Outcome?. JAMA cardiology, 6(1), 78. https://doi.org/10.1001/jamacardio.2020.5616
Shah, Sanjiv J. "Risk Marker Fatigue-Is There an Actionable Outcome?." JAMA cardiology vol. 6,1 (2021): 78. doi: https://doi.org/10.1001/jamacardio.2020.5616
Shah SJ. Risk Marker Fatigue-Is There an Actionable Outcome?. JAMA Cardiol. 2021 Jan 01;6(1):78. doi: 10.1001/jamacardio.2020.5616. PMID: 33206124.
Copy Download .nbib Format: NLM
Share it on

JAMA Cardiol. 2021 Jan 01;6(1):78. doi: 10.1001/jamacardio.2020.5616.

Risk Marker Fatigue-Is There an Actionable Outcome?.

JAMA cardiology

Sanjiv J Shah

Affiliations

  1. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  2. Associate Editor, JAMA Cardiology.

PMID: 33206124 DOI: 10.1001/jamacardio.2020.5616

[No abstract available.]

MeSH terms

Publication Types